文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症儿科与产科急症

接受连续肾脏替代治疗的危重儿童和年轻成人多器官功能障碍模式与肾脏恢复情况

Patterns of Multiple Organ Dysfunction and Renal Recovery in Critically Ill Children and Young Adults Receiving Continuous Renal Replacement Therapy.
PubMed 文献 · Crit Care Explor · 2024-05-06
一句话结论在危重儿童和年轻成人中,97%接受CRRT者在启动时已发生MODS,71%在30天时出现MAKE30,肾脏未恢复与特定肾外器官功能障碍及进展性MODS独立相关。

该回顾性队列纳入两所大型四级儿科医院2014至2020年接受CRRT的26岁及以下患者(排除慢性肾脏病),共373例,中位年龄84月。采用PELOD-2评分评估器官功能障碍,MODS定义为≥2个器官功能障碍,主要终点为30天主要不良肾脏事件(MAKE30)。CRRT启动时97%患者发生MODS,266例(71%)出现MAKE30;CRRT启动时急性肾损伤(aOR 3.55)、神经功能障碍(aOR 2.07)、血液/肿瘤功能障碍(aOR 2.27)及进展性MODS(aOR 1.11)与MAKE30独立相关。作者认为,在探讨肾脏恢复的临床试验设计中应纳入现有肾外器官支持策略及可改变的危险因素。

要点

  • CRRT启动时97%的危重儿童和年轻成人AKI-D患者已发生MODS(定义为≥2个器官功能障碍)。
  • 71%(266/373)的患者在30天时出现MAKE30(eGFR较基线下降≥25%、需要肾脏替代治疗或死亡)。
  • CRRT启动时急性肾损伤(aOR 3.55)、神经功能障碍(aOR 2.07)、血液/肿瘤功能障碍(aOR 2.27)与MAKE30独立相关。
  • 进展性MODS与MAKE30独立相关(aOR 1.11),肾脏未恢复与特定肾外器官功能障碍及进展性MODS相关。
  • PELOD-2评分从ICU入住时中位6分(IQR 3-9)升至CRRT启动时中位9分(IQR 7-12)。

适用人群与场景

  • 26岁及以下、2014至2020年在两所大型四级儿科医院接受CRRT的患者。
  • 排除慢性肾脏病患者。

诊断标准与关键阈值

  • MODS定义为大于或等于两个器官功能障碍。
  • 器官功能障碍采用儿童逻辑器官功能障碍-2(PELOD-2)评分评估。
  • 主要终点MAKE30定义为30天时估算肾小球滤过率较基线下降大于或等于25%、需要肾脏替代治疗或死亡。

研究设计与关键结果

  • 研究类型为回顾性队列,纳入两所大型四级儿科医院373例患者,50%为女性,中位年龄84月(IQR 16-172)。
  • PELOD-2从ICU入住时中位6分(IQR 3-9)升至CRRT启动时中位9分(IQR 7-12)。
  • CRRT启动时97%的患者发生MODS,266例(71%)出现MAKE30。
  • CRRT启动时急性肾损伤与MAKE30独立相关(aOR 3.55 [IQR 2.13-5.90])。
  • CRRT启动时神经功能障碍与MAKE30独立相关(aOR 2.07 [IQR 1.15-3.74])。
  • CRRT启动时血液/肿瘤功能障碍与MAKE30独立相关(aOR 2.27 [IQR 1.32-3.91])。
  • 进展性MODS与MAKE30独立相关(aOR 1.11 [IQR 1.03-1.19])。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在探讨肾脏恢复的临床试验设计中,应纳入目前可用的肾外器官支持策略(如治疗性血浆置换、肺保护性通气)及其他可改变的危险因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Acute kidney injury requiring dialysis (AKI-D) commonly occurs in the setting of multiple organ dysfunction syndrome (MODS). Continuous renal replacement therapy (CRRT) is the modality of choice for AKI-D. Mid-term outcomes of pediatric AKI-D supported with CRRT are unknown. We aimed to describe the pattern and impact of organ dysfunction on renal outcomes in critically ill children and young adults with AKI-D.

DESIGN: Retrospective cohort.

SETTING: Two large quarternary care pediatric hospitals.

PATIENTS: Patients 26 y old or younger who received CRRT from 2014 to 2020, excluding patients with chronic kidney disease.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Organ dysfunction was assessed using the Pediatric Logistic Organ Dysfunction-2 (PELOD-2) score. MODS was defined as greater than or equal to two organ dysfunctions. The primary outcome was major adverse kidney events at 30 days (MAKE30) (decrease in estimated glomerular filtration rate greater than or equal to 25% from baseline, need for renal replacement therapy, and death). Three hundred seventy-three patients, 50% female, with a median age of 84 mo (interquartile range [IQR] 16-172) were analyzed. PELOD-2 increased from 6 (IQR 3-9) to 9 (IQR 7-12) between ICU admission and CRRT initiation. Ninety-seven percent of patients developed MODS at CRRT start and 266 patients (71%) had MAKE30. Acute kidney injury (adjusted odds ratio [aOR] 3.55 [IQR 2.13-5.90]), neurologic (aOR 2.07 [IQR 1.15-3.74]), hematologic/oncologic dysfunction (aOR 2.27 [IQR 1.32-3.91]) at CRRT start, and progressive MODS (aOR 1.11 [IQR 1.03-1.19]) were independently associated with MAKE30.

CONCLUSIONS: Ninety percent of critically ill children and young adults with AKI-D develop MODS by the start of CRRT. Lack of renal recovery is associated with specific extrarenal organ dysfunction and progressive multiple organ dysfunction. Currently available extrarenal organ support strategies, such as therapeutic plasma exchange lung-protective ventilation, and other modifiable risk factors, should be incorporated into clinical trial design when investigating renal recovery.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Thadani S, Fuhrman D, Hanson C, et al. Patterns of Multiple Organ Dysfunction and Renal Recovery in Critically Ill Children and Young Adults Receiving Continuous Renal Replacement Therapy. Crit Care Explor. 2024. PMID: 38709083. doi:10.1097/CCE.0000000000001084

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。